In tumor cells, dysregulated expression of IL-3 is the molecular basis for survival and proliferation [11, 43, 46, 49] leading to malignancies, including mast cell leukemia (MCL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). The gene discussed is IL3; the disease is acute myeloid leukemia.